Søgning på udtrykket 'hepatitis' giver 101 resultater


Dokumenter [11] Sider [5] Kalender [44] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [11]

Version 8 er udarbejdet af en arbejdsgruppe nedsat af Dansk Selskab for Infektionsmedicin samt Dansk Selskab for Gastroenterologi og Hepatologi Medlemmer: Nina Weis (formand), Mette Rye Clausen, Peer Brehm Christensen, Henrik Krarup, Alex Lund Laursen, Lone Galmstrup Madsen

Diagnostik, behandling og forebyggelse af infektion med hepatitis A virus (HAV)

Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).

Anbefaling for profylakse og opfølgning af stikuheld og anden blodeksposition. Arbejdsgruppe: Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis

Udarbejdet af en arbejdsgrupper bestående af medlemmer fra Dansk Selskab for Infektionsmedicin og Dansk Transplantationsselskab

I forbindelse med Sundhedsstyrelsens udgivelse af "Personer med øget risiko ved COVID-19. Fagligt grundlag", har DSI beskrevet følgende specialespecifikke patienter med øget risiko for et alvorligt COVID-19 sygdomsforløb.

Sider [5]

…rede guidelines. Antiretroviral terapi: Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Olav Larsen, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smittede personer, Fertilitetsbehandling ved HIV og hepatitis B og C, HIV behandling af gravide, HIV post exposure profylakse (PEP), Pre-exposure profylakse mod HIV (PrEP), Borrelia: Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klaringsrapport, COVID-19: Marie H…

…ioner: Dato for næste kursus Efterår 2024 (2 dage) : Sted Endnu ikke afklaret Delkursusledelse Jakob Bodilsen og Lars Omland Tidligere kurser 11. og 12. april 2018 9. og 10 september 2021 Gastroenterologiske infektioner og kronisk hepatitis: Dato for næste kursus Efterår 2023: Sted Hvidovre Hospital Delkursusledelse Lone Mygind, Micha Jepsen og Belinda Mössner Tidligere kurser 3. og 4. december 2020 HIV-infektion: Dato for næste kursus 12. og 13. oktober…

…ogiske oversigter (slides). www.natap.org/. National AIDS Treatment Advocacy Project ? en New York State non-profit NGO ledet af Jules Levin (som selv lever med Hiv og hepatitis). God side, hvis man mangler slides/figurer/tabeller fra studier præsenteret på senest afholdte konferencer kommer ofte med referat (inklusive Jules Levins fortolkning ud fra et patient/aktivist perspektiv). www.clinicaloptions.com/HIV.aspx. Et andet website for opdateringer og sammendrag af konferencer (slides).

Formål: Rejsefondens formål er at yde økonomisk støtte til lægelige medlemmer af DSI med henblik på deltagelse på følgende kongresser: NSCMID, ECCMID, IDWeek, HIV og Hepatitis Nordic Conference, EACS/Glasgow HIV og CROI.   Hvad kan der søges om?: Der kan søges om økonomisk støtte til registreringsafgift, rejseudgifter og indlogering til de respektive kongresser. Det er ikke et krav at man har et videnskabeligt bidrag på kongressen. Man kan højest få tildelt støtte til én kongres å…


Kalender [44]

28. juli, Globalt
17. juni, Auditorium 3+4, Hvidovre Hospital
10. maj, Auditorium 3+4, Hvidovre Hospital
28. oktober 2020, Paris, Frankrig
17. september 2020, Auditorium 3-4, Hvidovre Hospital
25. november 2019, Auditorium 3 og 4, Hvidovre Hospital
25. september 2019, London, England
11. september 2019, DGI-byen, København
22. maj 2019, Rom, Italien
10. maj 2019, Auditorium 3 og 4, Hvidovre Hospital
15. februar 2019, Auditorium, University of Southern Denmark, J. B. Winsløws Vej 25, Odense
24. januar 2019, Aarhus Universitetshospital
28. november 2018, Hvidovre Hospital
30. maj 2018, Rom, Italien
4. maj 2018, Hindsgavl, Middelfart
9. april 2018, Amsterdam, Holland
12. december 2017, Auditorium 3 og 4, Hvidovre Hospital
14. september 2017, IDA Mødecenter, Kalvebod Brygge 31, 1560 København V
30. maj 2017, Hvidovre Hospital
25. maj 2016, Rom, Italien
3. juni 2015, Barcelona, Spanien
24. marts 2015, Auditorium 3+4, Hvidovre Hospital
13. november 2014, Auditorium 3-4, Hvidovre Hospital
24. oktober 2014, Rigshospitalet
9. oktober 2014, Frankfurt, Tyskland
18. juli 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
23. maj 2014, Aud. 3 og 4, Hvidovre Hospital, Kettegård Allé 30, 2650 Hvidovre
26. marts 2014, Barcelona, Spanien
30. juni 2013, Kuala Lumpur, Malaysia
20. marts 2013, Rom, Italien
25. oktober 2012, Danmarks Medie- og Journalisthøjskole
7. november 2011, Auditorium 93, Rigshospitalet
24. maj 2011, Rigshospitalet, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
12.08.2022
by Olivier Schorr, Sarah Blach, Christine Thurnheer, Christian Ruis, Jean-Francois Dufour. Aims of the study Since 2014, the Swiss Hepatitis Strategy (SHS) has targeted the elimination of Hepatitis C Virus (HCV) in Switzerland. The epidemiology of HCV is diverse across Swiss cantons, therefore cantonal-level screening and treatment strategies should be developed. This study aimed to identify scenarios to achieve HCV elimination in the canton of Bern by 2030. Methods A preexisting Markov disease burden mod…
Journal of Infectious Diseases
11.08.2022
AbstractBackgroundThe trajectory of liver fibrosis is not well understood in the contemporary era of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) therapy.MethodsWe assessed the Enhanced Liver Fibrosis (ELF) score, aspartate transaminase-to-platelet ratio index (APRI) and Fibrosis-4 (FIB-4) in 116 women with HIV/HCV coinfection over a 4-year period. Random-effects linear regression models examined the rate of fibrosis change 1–2 years before starting HCV treatment, within 1 year before st…
Journal of Medical Virology
10.08.2022
Journal of Medical Virology, Accepted Article.
PLoS One Infectious Diseases
5.08.2022
by María Belén Pisano, Christopher Campbell, Chimaobi Anugwom, Viviana Elizabeth Ré, José D. Debes. . In the United States (U.S.), a hepatitis E virus (HEV) seroprevalence between 6 and 21% has been described, with a decreasing trend. We aimed to investigate HEV infection in the U.S. population from 2009 to 2016, and examine the differences in seroprevalence using different assays. We used data from the National Health and Nutrition Examination Survey (NHANES-CDC) to estimate HEV seroprevalence and an…
Science Advances
5.08.2022
Science Advances, Volume 8, Issue 31, August 2022.
Current Opinion in Infectious Diseases
1.08.2022
Purpose of the review . . Passage of the HOPE Act and the advent of direct-acting antiviral (DAA) therapies have allowed for expansion of the donor organ pool to include donors with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), thus providing new opportunities for waitlist candidates. This article provides updates on recent studies in solid organ transplantation (SOT) utilizing donors with HIV and HCV. . Recent findings . . The first pilot studies of kidney and liver transplantation …
Infection
1.08.2022
. Abstract. . Background. The COVID-19 pandemic significantly compromised screening, laboratory controls, clinical surveillance and treatment of chronic hepatitis patients and worsened their outcome, as evidenced by its significant correlation with advanced cirrhosis, liver decompensation and mortality. . . Results. This pandemic sign…
BMC Infectious Diseases
1.08.2022
. Abstract. . Background. China has experienced a continuous decreasing trend in the incidence of hepatitis A in recent years. Temporal trend analyses are helpful in exploring the reasons for the changing trend. Thus, this study aims to analyse the incidence trend of viral hepatitis A by region and age group in mainland China from 2004 to 2017 to evaluate the effectiveness of prevention and control measures. …
International Journal of Infectious Diseases
27.07.2022
The worldwide outbreak of severe acute hepatitis with unknown etiology in children has raised an alert around the world for its speed and severity (World Health Organization [WHO], 2022). One paper by Nishiura et al. (Nishiura et al., 2022) drew a conclusion that prior exposure to Omicron variant might be associated with an increased risk for severe hepatitis among children only by comparing the absolute number of Omicron cumulative cases between the hepatitis-detected countries and hepatitis-undetected one…
BMC Infectious Diseases
27.07.2022
. Abstract. . Background. Direct-acting antivirals (DAAs) are highly effective in achieving sustained virologic response among those with chronic hepatitis C virus (HCV) infection. Quality of life (QOL) benefits for an HCV-infected population with high numbers of people who inject drugs and people living with HIV (PLHIV) in Eastern Europe have not been explored. We estimated such benefits for Ukraine. …
BMC Infectious Diseases
27.07.2022
. Abstract. . Background. Direct-acting antivirals (DAAs) are highly effective in achieving sustained virologic response among those with chronic hepatitis C virus (HCV) infection. Quality of life (QOL) benefits for an HCV-infected population with high numbers of people who inject drugs and people living with HIV (PLHIV) in Eastern Europe have not been explored. We estimated such benefits for Ukraine. …
Lancet
23.07.2022
July 28 marks World Hepatitis Day. Hepatitis B and C are the two major forms of viral hepatitis, causing inflammation, damage to the liver, and sometimes cancer. Their burden is huge—more men acquired hepatitis B (890 000 cases) in 2019–20 than HIV (720 000 cases). In 2019, HIV caused 0·7 million deaths, whereas hepatitis B and C combined caused 1·1 million deaths. Despite these large numbers, there is cause for optimism. The past decade has transformed viral hepatitis care. The development of dir…
PLoS One Infectious Diseases
21.07.2022
by Chun-Hsiang Wang, Ruey-Chang Lin, Hua-Yin Hsu, Yuan-Tsung Tseng. . Postmenopausal women with hepatitis B virus (HBV) infection are more likely to have accelerated liver fibrosis, eventually advancing to liver cirrhosis or hepatocellular carcinoma (HCC). The association between sex hormones and HBV-related HCC risk is unclear. We investigated whether hormone replacement therapy (HRT) is beneficial to postmenopausal women with HBV infection. This retrospective study selected the data of 44,465patients wi…
Journal of Medical Virology
21.07.2022
Journal of Medical Virology, Accepted Article.
Journal of the American Medical Association
19.07.2022
Despite recent progress, more than 350 million people globally live with viral hepatitis and more than 1 million die annually—a greater toll than from HIV and malaria combined. Amid unexplained increases in childhood hepatitis cases in 34 countries, the World Hepatitis Alliance and World Health Organization (WHO) urged renewed efforts to eliminate viral hepatitis by 2030, according to a joint statement.
New England Journal of Medicine
13.07.2022
New England Journal of Medicine, Ahead of Print.
New England Journal of Medicine
13.07.2022
New England Journal of Medicine, Ahead of Print.
New England Journal of Medicine
13.07.2022
New England Journal of Medicine, Ahead of Print.

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
12.08.2022
Progress has occurred in reducing maternal-to-child transmission of hepatitis B, a leading cause of liver cancer, but is lagging, particularly in Africa. .
Morbidity and Mortality Weekly Report (MMWR)
11.08.2022
This report describes percentage of adults with current hepatitis C virus by health insurance coverage.
Morbidity and Mortality Weekly Report (MMWR)
9.08.2022
This report describes hepatitis C treatment among insured adults in the United States.
Eurosurveillance latest updates
4.08.2022
Following the report of an excess in paediatric cases of severe acute hepatitis of unknown aetiology by the United Kingdom (UK) on 5 April 2022, 427 cases were reported from 20 countries in the World Health Organization European Region to the European Surveillance System TESSy from 1 January 2022 to 16 June 2022. Here, we analysed demographic, epidemiological, clinical and microbiological data available in TESSy. Of the reported cases, 77.3% were 5 years or younger and 53.5% had a positive test for ad…
Morbidity and Mortality Weekly Report (MMWR)
28.07.2022
This report describes global progress towards the elimination of mother-to-child hepatitis B virus.
ProMED
20.07.2022
Hepatitis A -- United States
Medscape Infectious Diseases
13.07.2022
90% of children in two new studies tested positive for the virus, but there was no evidence of viral infection in liver biopsies. .
ProMED
11.07.2022
Hepatitis E -- Sudan
Medscape Infectious Diseases
6.07.2022
Data from an ongoing study in patients with compensated cirrhosis and clinically significant portal hypertension have raised hope for an emerging treatment option in this rare, deadly disease. .
Medscape Infectious Diseases
6.07.2022
“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.” .
Medscape Infectious Diseases
25.06.2022
Almost all children (90%) required hospitalization, 18 needed liver transplants, and 11 children have died. .
Medscape Infectious Diseases
24.06.2022
Experts update the latest case numbers for acute hepatitis in children and discuss possible factors that result in the disease, namely, adenovirus and COVID-19, either separately or together. .
Morbidity and Mortality Weekly Report (MMWR)
24.06.2022
This report describes children diagnosed with hepatitis of unknown cause during October 2021 to June 2022. Preliminary analyses have not identified common exposures.
ProMED
19.06.2022
Hepatitis A -- Lebanon

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,467 s

Cookies og privatliv